This article has Open Peer Review reports available.
Hepatitis B Infection among high risk population: a seroepidemiological survey in Southwest of Iran
© Khosravani et al.; licensee BioMed Central Ltd. 2012
Received: 7 February 2012
Accepted: 28 November 2012
Published: 27 December 2012
Hepatitis B virus (HBV) infection remains a major global health problem. This study aimed to assess the prevalence and risk behaviors for HBV infection among high risk groups in Kohgiloyeh and Boyerahmad province, in Southwest of Iran.
Blood samples were collected from 2009 subjects, between 2009 and 2010 in Kohgiloyeh and Boyerahmad province, in southwest of Iran. Recruited subjects were the high risk groups for HBV infection, including inmates, injecting drug users, health care workers, patients on maintenance haemodialysis, hemophilic patients and patients with a history of blood transfusion. Their serum samples were tested for the presence of antibodies to hepatitis B core antigen (HBc IgM, IgG) by enzyme-linked immunosorbent assay (ELISA). Seropositive specimens were tested for HBsAg. Demographic features of participants were recorded during sample collecting.
HBsAg was detected in 24 of the 2009 subjects, giving an overall prevalence of 1.2%. All HBsAg positive cases were males. The prevalence of HBsAg among injection drug users was 3.2%. Significant correlation was found between HBV infection and drug abuse, level of education and place of residence (p<0.05), while no significant correlation was found between HBV infection and previous history of blood transfusion, unprotected sexual behavior, and thalassemia.
Based on the findings of this study, incarceration and drug abuse are the most important risk factors for acquiring HBV infection in this region. Modifying behavior, improving the individual education and expanding the HBV vaccination coverage may reduce the rate of infection in the region.
Hepatitis B virus (HBV) a member of hepadenaviridae family is the causative agent of hepatitis B infection. This infection remains a major global public health problem. In spite of the availability of a highly effective vaccine against hepatitis B infection, the overall burden of the disease remains enormous with over two billion people infected worldwide and about one million deaths annually [1, 2].
It has been estimated that at the most, 33% of the infected people have evidence of clinical hepatitis, and depending on the age of infection, up to one third of infected patients become chronic carriers of hepatitis B surface antigen (HBsAg) .
Transmissions may occur through sexual intercourse, parenteral contact or from an infected mother to the baby at birth (4). HBV also shares similar characteristics to the HIV transmission, the virus has been detected in peripheral mononuclear cells, tissue of pancreas, kidney, skin, and spleen and of fluids like semen, breast milk, sweat, tears, urine and vaginal secretion [4, 5].
The prevalence of hepatitis B infection varies in different parts of the world, ranging from less than 1% to 15%. In the Middle East, the endemicity is intermittent, with a carrier rate of 2% to 8% [6–9].
A systematic review on HBV infection in Iran revealed that prevalence of this infection is approximately 2.14% (range, 1.3% to 6.3%) across provinces . The prevalence of HBV infection is higher among males than females in Iran . Knowledge about the rate of hepatitis B infection and its related risk factors are necessary for implementating any preventive program. The present study was conducted to assess the prevalence and risk behaviors associated with HBV infection among high risk groups in Kohgiloyeh and Boyerahmad province, in Southwest of Iran. These high risk groups are the most vulnerable groups for acquiring HBV infection and have not been looked at in prior prevalence studies in the region.
This descriptive cross-sectional study was carried out in Kohgiloyeh and Boyerahmad province, in southwest of Iran. A structured questionnaire containing demographics data such as age, gender, education level was used to collect the data. High risk populations for HBV infection including those who had a history of blood transfusion, history of intravenous drug use, history of incarceration, those with unsafe sexual activities, health care workers, patients on maintenance haemodialysis, hemophilic patients from main three townships of the province (Yasouj, Gachsaran, and Dehdasht) were the subjects of this study.
Risk factors associated with HBV infection in high risk groups
History of imprisonment
History of using injecting drug
Unprotected sex activities
Collected data were analyzed by SPSS version 17 software. The standard chi square test was used to assess the correlation of demographic and behavioral variables and HBV infection.
Two thousand and nine high risk people for HBV from three main townships of Kohgiloyeh & Boyerahmad providence were included in this study. Among them 802 (39.9%) were from Yasouj, 803 (40%) from Gachsaran and 404 (20.1%) were from Dehdasht. There were 1240 males (69.1%) and 555 females (30.9%). The mean age of the participants was 34.9 years (range, 2 to 82 years). The majority (39.6%) were in the 21–30 year age group.
The overall prevalence of HBV infection in this population was 1.2%. Considering the sex of participants, males were more susceptible to HBV infection. HBV infection was found to be more prevalent among those who were working in private sectors (3.8%) in comparison with state or health care workers. The prevalence of HBV infection was 3.2% among injection drug users. The highest rate of infection (4.2%) was seen among immigrant people while the highest rate of infection among native people was 1.2%. Regarding the place of residence, Yasouj (1.4%) had the highest rate of infection followed by Gachsaran (1.2%) and Dehdasht (0.65%). Rate of infection in inmates was 1.2% while none of hemophilia and thalassemia patients were found to be positive.
Association between HBs antigen positivity and high risk behavior in high risk groups in Kohgiloyeh and Boyerahmad province, southwest of Iran
High risk behavior
95.0% C.I. for EXP(B)
History of drug use
History of imprisonment
Hepatitis B virus infection is a public health problem and a major cause of morbidity and mortality particularly in developing countries . The world can be divided into three areas where the prevalence of chronic HBV infection is: high (>8%), intermediate (2-8%), and low (<2%) [8, 9]. Most countries in the world are still considered intermediate to high endemicity for HBV infection [8, 9]. In Iran the prevalence of hepatitis B varies between 1.3 to 6.3% in different areas of the country . Because of lack of information about HBV infection in southwest of Iran the present study was conducted to look at the seroprevalence of HBV in high risk groups in this area.
A prevalence of 1.2% was found for HBV infection among the participant in this study. Comparing the findings of this study with other reports from the country, lower prevalence of HBV can be seen in this area [10, 11]. Findings of this study demonstrated a relatively low prevalence of HBV in the region. Since the recruited subjects of this study are the selected high risk groups, therefore the rate of HBV in whole population of the district might be different. This low rate of HBV infection in the province might be connected to HBV vaccination coverage in this area. National levels of HBV1, HBV2 and HBV3 vaccination coverage in Iran have been reported to be 98.9%, 98.8% and 98.4% respectively. Vaccination coverage of HBV in Kohgiloyeh and Boyerahmad province is up to 99.5% .
In a recent study the overall prevalence of HBsAg positivity among general population in northeast of Iran was found to be 1.39% which is higher than the rate of infection in our study .
An unexpected observation in this study was that all positive HBV infections were males. There was no obvious explanation for the difference in gender, as a risk factor, for these viral infections. Having no infection in females might be due to the high risk groups which were evaluated in this study. Positive cases are all among those with a history of imprisonment or history of using injection drugs. More than 95% of these two groups were males. Furthermore, most of females participants in this study were either health care workers (with a well coverage of HBV vaccination), or those with history of tattooing, history of surgery, etc. and these factors are not as important as history of imprisonment or history of using injecting drug. In contrary to our findings, some studies demonstrated a lower prevalence of HBV infection in males than females .
Intravenous drug users are at higher risk for HBV infection, primarily through high risk sexual activities and sharing unsterile needles. The prevalence of HBsAg among male injecting drug users (IDUs) in Tehran, Iran, was reported to be 5.8% while in Zahedan, Southeast of Iran, rate of HBV in hospitalized injection drug users was found to be 19.3% . In another study, the prevalence of HBV infection among hospitalized intravenous drug users in Ahvaz, southwest Iran, was 3.6% .
In our study the prevalence of HBV infection among injection drug users was 3.16% which is slightly lower than those reported from Tehran or other parts of the country .
Rate of HBV infection in prisoners in our study was 2.1% and a positive correlation was found between being in prison and seropositivity to HBV. This is again much lower than the rate of infection in incarcerations in other parts of the country. A study in south of Iran, in Bushehr province, reported a rate of 16.7% of HBV infection in prisoners .
In our study none of the hemophilic or thalassemic patients were positive for HBV infection. Repeated blood transfusions, as in thalessemia cases, are among the highest risk factors for HBV and HCV infection. In an interesting study in Bangladesh, the prevalence of transfusion-mediated viral infections in multi-transfused thalassemics individuals has been evaluated prior to initiate blood transfusion and after the subjects have received an average of 17 blood transfusions over a ten-month study period. The HBV and HCV markers have been significantly higher in post-transfused subjects as compared to pre-transfusion levels (for HBsAg; 19.0 vs. 7.1%) . Correlation between thalessemia and hemophilia and HBV infection were insignificant in our study and this might be due to the limited number of cases in our study.
The proper screening of donated blood in blood banks, regarding HBV infection, and high coverage of vaccination of people who are afflicted by hemophilia, thalassemia might be contributed to the low rate of infection in these high risk groups.
Iranian blood transfusion organization (IBTO) is the only nationally qualified organization in Iran that performs blood transfusion procedures. This government-based organization provides its services free of charge. According to the most recent estimations, there are 23 blood donors per 1000 population. Only in 2005, the IBTO produced 1,600,000 units of blood for transfusion purposes. Approximately 96% of blood donations in Iran are collected from voluntary non-remunerated blood donors and the rest (4%) is donated as family replacement donation . Khedmat et al., (2007) reported a rate of 0.487% for HBs antigen in Iranian blood donors .
The finding of this study showed that the people with a history of vaccination were infected by hepatitis B with a rate of 0.6% and non-vaccinated people with a rate of 2.3%. In current study, from all the subjects, 53% had a history of at least one dose of HBV vaccination. HBV infection was less prevalent (0.6%) in vaccinated individuals and there was a significant correlation between increasing number of vaccine doses and decreasing the rate of HBV infection.
In conclusion, it is essential to assess the magnitude of the problem of HBV infection in each region of the country. Findings of the present study provided epidemiological features of hepatitis B and its risk factors in Kohgiloyeh and Boyerahmad province in Southwest of Iran. This information may help to restrain the spread of HBV infection in this and other similar settings in the country. The findings may also help the health authorities for better implementation of any prevention and control program.
This study was financially supported by the governor of Kohgiloyeh and Boyerahmad province. We thank the medical and nursing staff of Shahid Beheshti and Imam Sadjjad hospitals for their help with sample collecting. Special thanks go to those who provided the blood samples for this study. Technical assistance of Dr M. Zoladl is acknowledged.
- Lavanchy D: Hepatitis B virus epidemiology, disease burden, treatment and current emerging prevention and control measures. J Viral Hepat. 2004, 11: 97-107. 10.1046/j.1365-2893.2003.00487.x.View ArticlePubMedGoogle Scholar
- Pungpapoong S, Kim WR, Poterucha JJ: Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clinic Proceeding. 2007, 82: 967-975. 10.4065/82.8.967.View ArticleGoogle Scholar
- McMabon BJ, Alward WL, Hall BD, Heyward WL, Bebder TR, Francis DP, Maynard JF: Acute hepatitis B virus infection: relation of age to clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985, 151: 599-603. 10.1093/infdis/151.4.599.View ArticleGoogle Scholar
- Maynard JE: Hepatitis B: global importance and need for control. Vaccine. 1990, 8 (suppl): 18-20.View ArticleGoogle Scholar
- Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L: Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011, 378: 571-583. 10.1016/S0140-6736(11)61097-0.View ArticlePubMedPubMed CentralGoogle Scholar
- Abdel-Hamid M, Ezzat S, El-Kafrawy S, Abdel-Latif S, El-Daly M, Turner P, Widell A, Strickland GT, Ismail A, Loffredo C: Viral, genetics and environmental risk factors for hepatocellular carcinoma in Egypt. Int J Virol. 2005, 1: 57-57.View ArticleGoogle Scholar
- Yuan H, Lee WM: Update of chronic hepatitis B. Curr Opin Gastroenterol. 2011, 27: 217-223. 10.1097/MOG.0b013e32834595b5.View ArticlePubMedGoogle Scholar
- Franco E, Bagnato B, Marino MG, Meleleo C, Serino L, Zaratti L: Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol. 2012, 27: 74-80.View ArticleGoogle Scholar
- Ott JJ, Stevens GA, Groeger J, Wiersma ST: Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012, 9: 2212-2219.View ArticleGoogle Scholar
- Alavian SM, Hajariazdeh B, AhmadzadAsl M, Kabir A, Bagheri Lankarani K: Hepatitis B virus infection in Iran: a systematic review. Hepat Mon. 2008, 8: 281-294.Google Scholar
- Alavian SM, Fallahian F, Lankarani KB: The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007, 16: 403-406.PubMedGoogle Scholar
- Esteghamati A, Keshtkar AA, Nadjafi L, Gouya MM, Salaramoli M, Roshande GH, Yaghini F: Hepatitis B vaccination coverage among Iranian children aged 15–26 months in 2006. East Mediterr Health J. 2011, 17: 19-26.Google Scholar
- Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR: The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011, 1: 346-350.Google Scholar
- Poorolajal J, Zali MR, Mohammad K, Farhadi A, Masjedi MR, Zargar A, Nowroozi A: Epidemiology of hepatitis B in the Islamic Republic of Iran. East Mediterr Health J. 1996, 2: 290-298.Google Scholar
- Alavi SM, Behdad F: Seroprevalence study of hepatitis C and hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002–2006). Hepat Mon. 2010, 10: 101-104.PubMedPubMed CentralGoogle Scholar
- Khamisipour GR, Tahmasebi R: Prevalence of HIV, HBV, HCV and syphilis infection in high risk groups of Bushehr Province. Iranian South Med J. 2000, 1: 53-59.Google Scholar
- Shekhar HU, Kabir Y, Hossain M, Uddin M, E-Jannat KK, Hossain S, Shahjalal H: Blood transfusion-mediated viral infections in thalassemic children in Bangladesh. J Med Sci. 2007, 7: 131-135.View ArticleGoogle Scholar
- Gharehbaghian A, Abolghasemi H, TabriziNamini M: Status of blood transfusion services in Iran. Asian J Transfus Sci. 2008, 2: 13-17. 10.4103/0973-6247.39505.View ArticlePubMedPubMed CentralGoogle Scholar
- Khedmat H, Fallahian F, Abolghasemi H, Alavian SM, Hajibeigi B, Miri SM, Jafari AM: Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors. Pak J Biol Sci. 2007, 10: 4461-4466.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/12/378/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.